Man­u­fac­tur­ing roundup: Teru­mo BCT part­ners with Bio­Bridge sub­sidiary to man­u­fac­ture cell and gene ther­a­pies; WuXi STA opens plant for HPA­PI pro­duc­tion

As the man­u­fac­tur­ing of cell and gene ther­a­pies is ramp­ing up and com­pa­nies are start­ing to in­vest in their man­u­fac­tur­ing ca­pa­bil­i­ties, Teru­mo Blood and Cell Tech­nolo­gies have formed a part­ner­ship to stay in the game.

Ac­cord­ing to the com­pa­ny, it has signed a new col­lab­o­ra­tive agree­ment with Gen­Cure, a sub­sidiary of Bio­Bridge Glob­al, to ex­tend and uni­fy cell and gene ther­a­py man­u­fac­tur­ing so­lu­tions.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER